Ijamsville, MD, United States of America

Les Sekut


Average Co-Inventor Count = 3.1

ph-index = 2

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 2003-2005

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Les Sekut: Innovator in ACE-2 Modulation

Introduction

Les Sekut is a notable inventor based in Ijamsville, MD (US). He has made significant contributions to the field of biotechnology, particularly in the modulation of ACE-2 activity. With a total of 2 patents, Sekut's work has implications for diagnosing and treating various diseases.

Latest Patents

Sekut's latest patents focus on methods and compositions for modulating ACE-2 activity. One patent discloses binding polypeptides that specifically bind to ACE-2 protein or ACE-2-like polypeptides. These binding polypeptides can be utilized for detecting, isolating, or purifying ACE-2 proteins in biological samples. Additionally, the invention includes nucleic acid molecules encoding these binding polypeptides, as well as methods for their production. Another patent relates to the use of angiotensin II in combination with angiotensin 1-9 to enhance vasoconstriction and treat disorders associated with low blood pressure.

Career Highlights

Les Sekut is currently associated with Human Genome Sciences, Inc., where he continues to innovate in the field of genetic research and biotechnology. His work has been instrumental in advancing our understanding of ACE-2 and its role in various health conditions.

Collaborations

Sekut has collaborated with notable colleagues such as Tom J Parry and Craig A Rosen, contributing to a dynamic research environment that fosters innovation.

Conclusion

Les Sekut's contributions to the field of biotechnology, particularly in ACE-2 modulation, highlight his role as a significant inventor. His patents not only advance scientific knowledge but also hold promise for future medical applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…